National Kidney Foundation Patient Network: Kidney Diseases and Conditions - Alport Syndrome - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
August 25, 2022 Newswires
Share
Share
Post
Email

National Kidney Foundation Patient Network: Kidney Diseases and Conditions – Alport Syndrome

Insurance Daily News

2022 AUG 25 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Staff editors report on the newly launched clinical trial, NCT05497518, which has the following summary description: “For chronic kidney disease (CKD), there is a lack of unique and powerful platform for patient engagement, research studies and public health advocacy work. The National kidney Foundation (NKF) launched the first nationwide registry for people at all stages and types of CKD, including people on dialysis and kidney transplant recipients, called the NKF Patient Network (NKFPatientNetwork.org). The NKF Patient Network is a non-interventional research study which means participants will not have to take medications or do any additional tests to participate. They are simply asked to share some personal and health information, and their experiences with their disease through a secure portal. The Network also collaborates with health systems to obtain additional electronic health records (EHR) data. This unique combination of data collected will address the gap of individualized educational resources and will enhance clinical research, clinical care, and health policy decisions to be centered on the patient. The NKF also partnered with the Alport Syndrome Foundation (ASF) on the NKF Patient Network - Alport Syndrome, a registry expansion that will contribute to research and treatments for Alport syndrome. The NKF Patient Network is all online and can be accessed any time of day at NKFPatientNetwork.org. Participation is voluntary and free.”

As a matter of record, on August 12, 2022, NewsRx staff editors report that the available information provided by Tufts Medical Center on this trial include:

Tracking Information

Trial Identifier NCT05497518
First Submitted Date August 9, 2022
First Posted Date August 11, 2022
Results First Submitted Date Not Provided
Results First Posted Date Not Provided
Last Update Submitted Date August 9, 2022
Last Update Posted Date August 11, 2022
Primary Completion Date February 24, 2070
Actual Start Date February 25, 2021
Current Primary Outcome Measures •Total number of enrolled participants [ Time Frame: 5 years ] -- Reach 10,000 enrolled participants
Current Secondary Outcome Measures Not Provided
Other Outcome Measures Not Provided
Change History Complete list of historical revisions of study NCT05497518

Descriptive Information

Brief Title A National Registry for People With All Stages of Kidney Disease: the National Kidney Foundation (NKF) Patient Network
Official Title National Kidney Foundation Patient Network
Brief Summary For chronic kidney disease (CKD), there is a lack of unique and powerful platform for patient engagement, research studies and public health advocacy work. The National kidney Foundation (NKF) launched the first nationwide registry for people at all stages and types of CKD, including people on dialysis and kidney transplant recipients, called the NKF Patient Network (NKFPatientNetwork.org). The NKF Patient Network is a non-interventional research study which means participants will not have to take medications or do any additional tests to participate. They are simply asked to share some personal and health information, and their experiences with their disease through a secure portal. The Network also collaborates with health systems to obtain additional electronic health records (EHR) data. This unique combination of data collected will address the gap of individualized educational resources and will enhance clinical research, clinical care, and health policy decisions to be centered on the patient. The NKF also partnered with the Alport Syndrome Foundation (ASF) on the NKF Patient Network - Alport Syndrome, a registry expansion that will contribute to research and treatments for Alport syndrome. The NKF Patient Network is all online and can be accessed any time of day at NKFPatientNetwork.org. Participation is voluntary and free.
Detailed Description The NKF Patient Network is a longitudinal prospective and retrospective observational cohort study of patient-entered data that collaborates with health systems to obtain additional electronic health records (EHR) data. The NKF also partnered with the Alport Syndrome Foundation (ASF) on the NKF Patient Network - Alport Syndrome, a registry expansion that will contribute to research and treatments for Alport syndrome. The NKF Patient Network and the NKF Patient Network - Alport Syndrome are approved by the Tufts Health Sciences Institutional Review Board, which serves as the IRB of record for all U.S. sites. The NKF Patient Network will start patient recruitment outside of the U.S. in 2022. The first international country will be Canada. The University of Manitoba, Winnipeg, MB, Canada is the Coordinating Site for all Canadian sites. Pulse Infoframe (Pulse) is the platform partner responsible for the development and implementation of the registry on their healthieTM 2.0 Amazon Web Services (AWS) Global Cloud platform and data management. All data collected through the NKF Patient Network is stored on the healthieTM 2.0 platform, a secure system that meets existing GDPR, HIPAA and other international established standards for privacy and security of health information. Several precautions are taken to assure the confidentiality of patients. Immediately after enrollment, each patient is assigned a GUID (Globally Unique IDentifier) and a study specific identifier, which is used to identify the patient’s database records. GUID is generated randomly and systemically and does not include other identifiers. The database employs multiple security features to limit access to any PHI to authorized study team members only. The computerized database tags all person identifying information (PII) and PHI data and not permit the viewing of such data except by authorized parties. Strict control over data viewing based on role-based permissions is enforced. De-identified aggregate data is available for analysis to the NKF and the partners of the NKF Patient Network via analytic portals, dashboards, and/or subscription reports depending on contractual agreements. The individual site’s data will be segregated from the rest of the registry, but the de-identified aggregate data can still be included in the overall registry’s dashboard, reports, and analytics. Research proposals by partners and outside investigators that require advanced statistical analysis for publications in peer-reviewed journals, abstracts, and/or posters must be submitted and approved according to the Data Use and Publications policy. The Data Coordinating Center (DCC) or Pulse, depending on the request, conduct the statistical analyses for all approved research proposals.
Study Type Observational [Patient Registry]
Study Phase Not Provided
Study Design Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration 50 Years
Condition Chronic Kidney Disease
Dialysis
Kidney Transplant
Alport Syndrome
Intervention •Other: Observational study - registry
The Network is a longitudinal observational cohort study that collaborates with health systems to obtain both electronic healthcare records (EHR) and patient-entered data. Eligible people with a diagnosis of chronic kidney disease at any stage, age 18 years and above, are identified through EHR data review, referral by a provider, or are recruited through the NKF’s outreach campaign. Patients self-enroll into the online registry and share their experiences and health data through a secure portal where they can also find education, tips, and support. Research partners can view aggregate data through a collaboration portal.
Study Arms •People with chronic kidney disease
No interventions will be administered as part of this registry.
Interventions:
⚬Other: Observational study - registry

Recruitment Information

Recruitment Status Recruiting
Estimated Enrollment 50000
Estimated Completion Date February 24, 2070
Primary Completion Date February 24, 2070 (Final data collection date for primary outcome measure)
Eligibility Inclusion Criteria: Patients with any stage of CKD, including kidney transplant recipients and patients on dialysis. Age 18 years and above. Patients with Alport syndrome who decide to register to the NKF Patient Network
•Alport Syndrome can be of any age. Willing to participate in the NKF Patient Network and complete the informed consent form and assent form (where applicable). Able to participate in this NKF Patient Network, which initially will be in English and then eventually expand to other languages. Patients affiliated with Geisinger Health System must have given their consent to Geisinger Health System IRB to be contacted for research projects. Exclusion Criteria: Patient not diagnosed with CKD Age below 18 years (only for patients without a diagnosis of Alport syndrome) Not willing to participate in the NKF Patient Network as well as unwilling to complete the informed consent form
Sex/Gender Sexes Eligible for Study: All
Ages 18 years to 120 years
Accepts Healthy Volunteers No
Contacts Primary contact: Lesley A Inker, MD, MS, 617-636-2569, [email protected]
Backup contact: Kerry Willis, PhD, 212-889-2210, [email protected]
Listed Location Countries United States
Removed Location Countries

Administrative Information

NCT Number NCT05497518
Other Study ID Numbers 10-500-1060
Has Data Monitoring Committee Not Provided
U.S. FDA-regulated Product Not Provided
Plan to Share Data No
Plan to Share Data (IPD) Description Not Provided
Responsible Party Tufts Medical Center
Collaborators National Kidney Foundation
Investigators Study Director: Kerry Willis, PhD, National Kidney Foudnation
Information Provided By Tufts Medical Center
Verification Date August 2022

(Our reports deliver fact-based news of research and discoveries from around the world.)

Older

Patent Issued for Dependency management in software development (USPTO 11409507): State Farm Mutual Automobile Insurance Company

Newer

CPA Liability Insurance Market Growth Holds Strong; Key Players Studied

Advisor News

  • Your client wants to cash out an annuity. Here’s what to consider
  • How student loan debt impacts 401(k) balances
  • The ‘sandwich generation’ faces compounded barriers to retirement savings
  • Benefit Costs Squeeze Schools, Driving Cuts, Tax Hikes And Difficult Tradeoffs
  • Why client insurance needs could change even if their life doesn’t
More Advisor News

Annuity News

  • SS&C Black Diamond Expands Annuities & Insurance Marketplace with New Insurance Capabilities and Carriers
  • Regulators urged to sharply limit hypothetical data in annuity illustrations
  • Your client wants to cash out an annuity. Here’s what to consider
  • Oklahoma Insurance Dept. helps Oklahomans recover unclaimed life insurance benefits
  • Bitcoin gains ground in retirement market with Equitable annuity option
More Annuity News

Health/Employee Benefits News

  • Missouri consumers could see Health Insurance Premiums jump up to 26 percent
  • New Findings from Johns Hopkins University in the Area of Managed Care Described (Medicaid and Health Resilience: Evidence From Tenncare Disenrollment): Managed Care
  • School workers may have no clarity on 2027 health insurance costs
  • Attorney General Tong Statement on Health Insurance Rate Hikes
  • Agent groups speaking out against possible moratorium on new ACA brokers
Sponsor
More Health/Employee Benefits News

Life Insurance News

  • Blankenbush receives distinguished insurance service award
  • National Life Group Included in Forbes List of America’s Best Insurance Companies for Third Year
  • New York Life Enhances Survivorship Variable Universal Life with Guaranteed Death Benefit Option
  • SS&C Black Diamond Expands Annuities & Insurance Marketplace with New Insurance Capabilities and Carriers
  • Oklahoma Insurance Dept. helps Oklahomans recover unclaimed life insurance benefits
Sponsor
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • Classic Car Insurer OpenRoad Insurance Expands to 40 U.S. States in Two Years
  • How Aspire General Turned an Early Technology Bet Into Claims Automation at Scale with Kyber
  • Adjusto launches AI-Native contents claims services powered by its technology platform
  • URL Insurance Group Celebrates 40 Years of Service, Growth, and Industry Leadership
  • MassMutual Ascend Surpasses $2 Billion in Lifetime Advisory Annuity Sales, Reflecting Continued Momentum in RIA Channel
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.